Kyverna Therapeutics (KYTX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Dec15

Kyverna Therapeutics Announces Positive Results of SPS Phase II Clinical Trial

11:30

Nov13

Kyverna Therapeutics released FY2025 9 Months earnings on November 12, 2025 (EST), actual revenue USD 0, actual EPS USD -2.8536

04:00

Kyverna Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual EPS USD -0.8473 (forecast USD -0.971)

04:00

Aug13

Kyverna Therapeutics released FY2025 Semi-Annual Earnings on August 12, 2025 (EST), with actual revenue of USD 0 and EPS of USD -2.0063

03:00

Kyverna Therapeutics released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.9735 (forecast USD -1.0438)

03:00

Jun30

Kyverna Therapeutics Appoints Marc Grasso as CFO

13:01

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -36.79 M, EPS -0.8473

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -42.08 M, EPS -0.9735

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -44.64 M, EPS -1.0328

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change